Refine by
Muscle Control Technology
4 companies found
Technologybased inPacé, FRANCE
Blueback markets a medical device that makes it easy and quick to assess the tone of the deep muscles. True innovation, Blueback Physio, supports healthcare professionals in this difficult but essential assessment in their ...
As often in entrepreneurship, the idea of BlueBack was born from a personal story. The story of a young woman who at the age of twenty, was forbidden to practice sports because of back pain. After a long medical journey (specialized doctor, ...
Technologybased inTempe, ARIZONA (USA)
CyMedica Orthopedics was founded in January 2013 by a prominent orthopedic surgeon and experienced medical device entrepreneurs with the desire to deliver faster, more predictable patient outcomes. CyMedica developed a therapy-based, digital health ...
The QB1 system gives patients the power to overcome quad weakness by integrating next-generation muscle activation technology in a simple compressive wrap or post-operative brace. It uses an integrated, handheld ...
Technologybased inRahway, NEW JERSEY (USA)
For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world — and today, we are at the forefront of ...
Antivenin (Latrodectus mactans) is a sterile, non-pyrogenic preparation derived by drying a frozen solution of specific venom-neutralizing globulins obtained from the blood serum of healthy horses immunized against venom of black widow spiders ...
Technologybased inNes-Ziona, ISRAEL
Kadimastem is a bio-pharmaceutical company that develops industrial regenerative medicine therapies based on differentiated cells derived from Human Embryonic Stem Cells (hESCs) to treat neuro-degenerative diseases such as ALS and Diabetes. ...
Clinical grade human astrocytes (the nervous system supporting cells) for the treatment of ALS and other neurodegenerative diseases. Received approval by the Israeli Ministry of Health to commence our phase I/IIa clinical trial in ALS patients. 6 ...